Search results
Cosmo Feilding Mellen CEO Cosmo is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances in order to help patients in need.
View Cosmo Feilding Mellen’s profile on LinkedIn, a professional community of 1 billion members. Experience: Beckley Psytech · Education: University of Oxford · Location: United Kingdom ·...
- Beckley Psytech
Cosmo Feilding Mellen is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances. In 2019, he co-founded Beckley Psytech, a private, clinical-stage biotechnology company on a mission to develop novel, rapid-acting, short-duration psychedelic medicines that address the huge unmet need of those ...
Feb 7, 2024 · I’m about to have lunch with pioneering drug campaigner Amanda Feilding, 81, and her youngest son Cosmo Feilding-Mellen, 39; between them they run two of the three arms of the Beckley...
Nov 23, 2021 · Cosmo Feilding-Mellen, CEO at Beckley Psytech. This possible clinical application for psychedelics would likely take the form of microdosing psilocybin (a technique which involves taking the substance at a low dose), Feilding-Mellen explains.
Cosmo Feilding Mellen CEO Cosmo is a drug development entrepreneur dedicated to unlocking the medical potential of psychoactive substances in order to help patients in need.
Cosmo Feilding Mellen. Cosmo is CEO at Beckley Psytech and a drug development entrepreneur dedicated to unlocking the medical potential psychoactive substances, in order to help patients in need.